UK experts call for joined-up approach to education and support
Study results announced today by Novo Nordisk and collaborative partners at the Diabetes UK conference show psychological support should be a priority for diabetes care in the UK, alongside improved education and self-management of the condition. The findings of the DAWN2â„¢ study show that more than a quarter (26%) of people with diabetes experience diabetes-related distress. Yet family members also experience distress, with around half (47%) worrying about low blood sugar (hypoglycaemic) events, and nearly one in ten (9%) family members having likely depression.
The DAWN2â„¢ global study of diabetes was conducted among 15,000 people in 17 countries, including 900 people with diabetes, family members, carers and healthcare professionals in the UK. Results from the DAWN2â„¢ study have found that participation in diabetes education is associated with a greater sense of wellbeing and ability to self-manage diabetes. However, over three-quarters of people with diabetes in the UK (78%) have never attended a diabetes education programme, and family members are rarely included (79%). Additionally, only 14% of healthcare professionals say that all their patients with diabetes are offered structured diabetes education classes.
Simon O’Neill, Director of Health Intelligence at Diabetes UK and DAWN2â„¢ steering committee member, said: “DAWN2 reveals the burden on families of those living with diabetes. Families are worried about their loved one’s future, fearful about aspects such as hypoglycaemia, and keen to help when it comes to self-management. We must take a person-centred approach to diabetes care that includes all those involved – the individual, their family network and the healthcare professional community. We need to work together to create a plan of care based on the person’s individual needsâ€.
In response to these findings, a national action plan has been launched to help improve diabetes care in the UK. The DAWN2â„¢ action plan has been developed by an independent, multidisciplinary group, with the support of Novo Nordisk, and will provide innovative tools and resources to people living with and caring for diabetes, as part of a three-year programme.